Jinyu Bio-Technology Co Documents
Documents
0
Ticker
600201.SS
ISIN
CNE000000Y37
Jinyu Bio-Technology Co SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Jinyu Bio-Technology Co Documents 2026
This page contains all official documents and SEC filings for Jinyu Bio-Technology Co stock (600201.SS, ISIN: CNE000000Y37). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Jinyu Bio-Technology Co's regulatory filings.
Jinyu Bio-Technology Co Stock analysis
Jinyu Bio-Technology Co Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas.